BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34966684)

  • 1. A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis.
    Sun S; Men Y; Kang J; Sun X; Yuan M; Yang X; Bao Y; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
    Front Oncol; 2021; 11():781340. PubMed ID: 34966684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of brain metastasis prediction model in limited stage small cell lung cancer patients without prophylactic cranial irradiation.
    Guo J; Liu J; Ye W; Xu J; Zhong W; Zhang X; Yuan H; Shi H; Li T; Xu Y; Mao J; Shen B; Wu D
    Clin Respir J; 2024 Jan; 18(1):e13730. PubMed ID: 38286746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer.
    Ding X; Dai H; Hui Z; Ji W; Liang J; Lv J; Zhou Z; Yin W; He J; Wang L
    Radiat Oncol; 2012 Jul; 7():119. PubMed ID: 22846375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
    Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J
    JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
    Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
    JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and validation of a nomogram for predicting brain metastases after chemotherapy and radiotherapy in male small cell lung cancer patients with stage III.
    Yang B; Zhang W; Qiu J; Yu Y; Li J; Zheng B
    Aging (Albany NY); 2023 Jul; 15(13):6487-6502. PubMed ID: 37433033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "Seed-and-Soil" Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation.
    Chu X; Gong J; Yang X; Ni J; Gu Y; Zhu Z
    Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and validation of a nomogram for predicting brain metastases in lung squamous cell carcinoma patients: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Zhang J; Xu J; Jin S; Gao W; Guo R; Chen L
    J Thorac Dis; 2021 Jan; 13(1):270-281. PubMed ID: 33569207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Sun X; Men Y; Wang J; Bao Y; Yang X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2021 May; 12(9):1358-1365. PubMed ID: 33728811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
    Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
    Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.
    Genre L; Roché H; Varela L; Kanoun D; Ouali M; Filleron T; Dalenc F
    Eur J Cancer; 2017 Feb; 72():200-209. PubMed ID: 28042991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resected non-small cell bronchogenic carcinoma stage pIIIA-N2. Which patients will benefit most from adjuvant therapy?].
    Gómez AM; Jarabo JR; Fernandez C; Calatayud J; Fernández E; Torres AJ; Balibrea JL; Hernando F;
    Cir Esp; 2014 Apr; 92(4):277-82. PubMed ID: 23453425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy.
    Xu X; Chen G; Fan S; Zhang Q; Huang W; Chen J; Ji W; Ma J; He J
    J Thorac Dis; 2024 Jan; 16(1):479-490. PubMed ID: 38410550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical nomogram and heat map for assessing survival in patients with stage I non-small cell lung cancer after complete resection.
    Cao X; Zheng YZ; Liao HY; Guo X; Li Y; Wang Z; Zhang L; Wang XD; Wang X
    Ther Adv Med Oncol; 2020; 12():1758835920970063. PubMed ID: 33224277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
    Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.